VICARIOUS SURGICAL INC-A (RBOT:NYSE)
$0.7 -0.1 (-12.5%)
Analysed VICARIOUS SURGICAL INC-A (RBOT:NYSE) News Sources
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
30-03-2026
yahoo.com
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
25-03-2026
yahoo.com
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
16-03-2026
yahoo.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results
09-03-2026
yahoo.com
Vicarious Surgical receives NYSE delisting notice
04-03-2026
medtechdive.com
Vicarious Surgical Receives Delisting Notice From NYSE
04-03-2026
yahoo.com
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)
03-03-2026
yahoo.com
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
12-01-2026
yahoo.com
Vicarious inks software partnership as it streamlines operations
06-01-2026
medtechdive.com
RBOT Enters Strategic Software Partnership to Streamline Development
30-12-2025
yahoo.com
What is the current price of VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The current price of VICARIOUS SURGICAL INC-A (RBOT:NYSE) is $0.7.
VICARIOUS SURGICAL INC-A (RBOT:NYSE) absolute price change since previous trading day?
The absolute price change of VICARIOUS SURGICAL INC-A (RBOT:NYSE) since the previous trading day is $-0.1.
VICARIOUS SURGICAL INC-A (RBOT:NYSE) percentage price change since previous trading day?
The percentage price change of VICARIOUS SURGICAL INC-A (RBOT:NYSE) since the previous trading day is -12.5%.
What is the most recent average sentiment score for VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The most recent average sentiment score for VICARIOUS SURGICAL INC-A (RBOT:NYSE) is 75 out of 100.
What is the most recent average sentiment for VICARIOUS SURGICAL INC-A (RBOT:NYSE)?
The most recent sentiment for VICARIOUS SURGICAL INC-A (RBOT:NYSE) is .
SEC-8K** Filing Available For VICARIOUS SURGICAL INC-A (RBOT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.